Obesity, fatty liver disease and intestinal microbiota

World Journal of Gastroenterology

Volumn 20, Issue 44, 2014, Pages 16452-16463

  Arslan, Nur ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Dysbiosis; Intestinal microbiota; Nonalcoholic fatty liver disease; Obesity

Indexed keywords

ALCOHOL; CARBOHYDRATE; CHOLINE; ENDOTOXIN; GASTROINTESTINAL HORMONE; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID;

ADIPOSE TISSUE; ALCOHOL PRODUCTION; ARTICLE; BACTERIAL OVERGROWTH; BILE ACID METABOLISM; CHILDHOOD OBESITY; CYTOKINE RELEASE; DIET THERAPY; ENTEROBACTERIACEAE; ENVIRONMENTAL FACTOR; FATTY LIVER; FOOD INTAKE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIPID PEROXIDATION; LIPID STORAGE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOW CALORY DIET; METABOLIC SYNDROME X; METAGENOMICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PORTAL VEIN; REGULATORY MECHANISM; WEIGHT CHANGE; WEIGHT REDUCTION; ANIMAL; BACTERIAL TRANSLOCATION; DYSBIOSIS; ENERGY METABOLISM; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; NON-ALCOHOLIC FATTY LIVER DISEASE; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIAL TRANSLOCATION; DYSBIOSIS; ENERGY METABOLISM; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINES; MICROBIOTA; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; SIGNAL TRANSDUCTION;

EID: 84918842602     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i44.16452     Document Type: Article

References (128)

1. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837-848 [PMID: 16497592 DOI: 10.1016/ j.cell.2006.02.017]
2. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241214 [PMID: 24009397 DOI: 10.1126/science.1241214]
3. Arslan N, Büyükgebiz B, Oztürk Y, Cakmakçi H. Fatty liver in obese children: prevalence and correlation with anthropometric measurements and hyperlipidemia. Turk J Pediatr 2005; 47: 23-27 [PMID: 15884625]
4. Sinatra FR. Nonalcoholic fatty liver disease in pediatric patients. JPEN J Parenter Enteral Nutr 2012; 36: 43S-48S [PMID: 22237875 DOI: 10.1177/0148607111421610]
5. Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol 2012; 9:152-161 [PMID: 22249728 DOI: 10.1038/nrgastro.2011.273]
6. Argo CK, Northup PC, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in nonalcoholic steatohepatitis. J Hepatol 2009; 51: 371-379 [PMID: 19501928 DOI: 10.1016/j.jhep.2009.03.019]
7. Berardis S, Sokal E. Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur J Pediatr 2014; 173: 131-139 [PMID: 24068459 DOI: 10.1007/s00431-013-2157-6]
8. Widhalm K, Ghods E. Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes (Pond) 2010; 34: 1451-1467 [PMID: 20838401 DOI: 10.1038/ijo.2010.185]
9. Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010; 7: 691-701 [PMID: 21045794 DOI: 10.1038/nrgastro.2010.172]
10. Vajro P, Paolella G, Fasano A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr 2013; 56: 461-468 [PMID: 23287807 DOI: 10.1097/MPG.0b013e318284abb5]
11. Demircioglu F, Koçyigit A, Arslan N, Cakmakçi H, Hizli S, Sedat AT. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease, J Pediatr Gastroenterol Nutr 2008; 47: 68-75 [PMID: 18607271 DOI: 10.1097/ MPG.0b013e31816232c9]
12. Iughetti L, De Simone M, Verrotti A, Iezzi ML, Predieri B, Bruzzi P, Bernasconi S, Balli F, Bedogni G. Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. Ann Hum Biol 2008; 35: 439-448 [PMID: 18654874 DOI: 10.1080/03014460802232714]
13. Balakrishnan PL. Identification of obesity and cardiovascular risk factors in childhood and adolescence. Pediatr Clin North Am 2014; 61: 153-171 [PMID: 24267463 DOI: 10.1016/ j.pcl.2013.09.013]
14. Gulati S, Misra A, Colles SL, Kondal D, Gupta N, Goel K, Bansal S, Mishra M, Madkaikar V, Bhardwaj S. Dietary intakes and familial correlates of overweight/obesity: a fourcities study in India. Ann Nutr Metab 2013; 62: 279-290 [PMID: 23689065 DOI: 10.1159/000346554]
15. Jafar TH, Qadri Z, Islam M, Hatcher J, Bhutta ZA, Cha tur vedi N. Rise in childhood obesity with persistently high rates of undernutrition among urban school-aged Indo-Asian children. Arch Dis Child 2008; 93: 373-378 [PMID: 17942586 DOI: 10.1136/adc.2007.125641]
16. Moraes SA, Beltran Rosas J, Mondini L, Freitas IC. [Prevalence of overweight and obesity, and associated factors in school children from urban area in Chilpancingo, Guerrero, Mexico, 2004]. Cad Saude Publica 2006; 22: 1289-1301 [PMID: 16751968]
17. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311: 806-814 [PMID: 24570244 DOI: 10.1001/ jama.2014.732]
18. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 2007; 11: 191-207, x-xi [PMID: 17544979]
19. Kikuchi L, Oliveira CP, Carrilho FJ. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Biomed Res Int 2014; 2014: 106247 [PMID: 24738043]
20. Calle EE, Rodriguez G, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638 [PMID: 12711737 DOI: 10.1056/NEJMoa021423]
21. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002; 36: 150-155 [PMID: 12085359 DOI: 10.1053/jhep.2002.33713]
22. Berentzen TL, Gamborg M, Holst C, Sorensen TI, Baker JL. Body mass index in childhood and adult risk of primary liver cancer, J Hepatol 2014; 60: 325-330 [PMID: 24076363 DOI: 10.1016/j.jhep.2013.09.015]
23. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121 [PMID: 16012941]
24. Speliotes E.K. , Wilier CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Lango Allen H, Lindgren CM, Luan J, Mägi R, Randall JC, Vedantam S, Winkler TW, Qi L, Workalemahu T, Heid IM, Steinthorsdottir V, Stringham HM, Weedon MN, Wheeler E, Wood AR, Ferreira T, Weyant RJ, Segrè AV, Estrada K, Liang L, Nemesh J, Park JH, Gustafsson S, Kilpeläinen TO, Yang J, Bouatia-Naji N, Esko T, Feitosa MF, Kutalik Z, Mangino M, Raychaudhuri S, Scherag A, Smith AV, Welch R, Zhao JH, Aben KK, Absher DM, Amin N, Dixon AL, Fisher E, Glazer NL, Goddard ME, Heard-Costa NL, Hoesel V, Hottenga JJ, Johansson A, Johnson T, Ketkar S, Lamina C, Li S, Moffatt MF, Myers RH, Narisu N, Perry JR, Peters MJ, Preuss M, Ripatti S, Rivadeneira F, Sandholt C, Scott LJ, Timpson NJ, Tyrer JP, van Wingerden S, Watanabe RM, White CC, Wiklund F, Barlassina G, Chasman DI, Cooper MN, Jansson JO, Lawrence RW, Pellikka N, Prokopenko I, Shi J, Thiering E, Alavere H, Alibrandi MT, Almgren P, Arnold AM, Aspelund T, Atwood LD, Baikau B, Balmforth AJ, Bennett AJ, Ben-Shlomo Y, Bergman RN, Bergmann S, Biebermann H, Blakemore AI, Boes T, Bonnycastle LL, Bornstein SR, Brown MJ, Buchanan TA, Busonero F Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.Nat Genet2010; 42: 937-948 [PMID: 20935630 DOI: 10.1038/ng.686]
25. Gregor MF, Hotamisligil GS. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease, J Lipid Res 2007; 48: 1905-1914 [PMID: 17699733 DOI: 10.1194/jlr.R700007-JLR200]
26. Arslan N, Erdur B, Aydin A. Hormones and cytokines in childhood obesity. Indian Pediatr 2010; 47: 829-839 [PMID: 21048235]
27. Machado MV, Coutinho J, Garepa F, Costa A, Proença H, Cortez-Pinto H. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2012; 24: 1166-1172 [PMID: 22735605 DOI: 10.1097/ MEG.0b013e32835609b0]
28. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80 [PMID: 19026645 DOI: 10.1053/j.gastro.2008.10.080]
29. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-1118 [PMID: 11352068 DOI: 10.1126/science.1058709]
30. Zoetendal EG, Vaughan EE, de Vos WM. A microbial world within us. Mol Microbiol 2006; 59: 1639-1650 [PMID: 16553872 DOI: 10.1111/j.1365-2958.2006.05056.x]
31. Chan YK, Estaki M, Gibson DL. Clinical consequences of diet-induced dysbiosis. Ann Nutr Metab 2013; 63 Suppl 2: 28-40 [PMID: 24217034 DOI: 10.1159/000354902]
32. Sekirov I, Russell SL, Antunes LG, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904 [PMID: 20664075 DOI: 10.1152/physrev.00045.2009]
33. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258-1270 [PMID: 22424233 DOI: 10.1016/ j.cell.2012.01.035]
34. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023 [PMID: 17183309 DOI: 10.1038/4441022a]
35. Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 2013; 62: 1505-1510 [PMID: 24037875 DOI: 10.1136/ gutjnl-2012-303954]
36. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075 [PMID: 16033867]
37. Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol 2012; 7: 91-109 [PMID: 22191449 DOI: 10.2217/fmb.11.142]
38. Sweeney TE, Morton JM. The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg 2013; 148: 563-569 [PMID: 23571517 DOI: 10.1001/jamasurg.2013.5]
39. Verdam FJ, Fuentes S, de Jonge C, Zoetendal EG, Erbil R, Greve JW, Buurman WA, de Vos WM, Rensen SS. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) 2013; 21: E607-E615 [PMID: 23526699 DOI: 10.1002/ oby.20466]
40. Bervoets L, Van Hoorenbeeck K, Kortleven I, Van Noten C, Hens N, Vael G, Goossens H, Desager KN, Vankerckhoven V. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog 2013; 5: 10 [PMID: 23631345 DOI: 10.1186/1757-4749-5-10]
41. Xu P, Li M, Zhang J, Zhang T. Correlation of intestinal microbiota with overweight and obesity in Kazakh school children. BMC Microbiol 2012; 12: 283 [PMID: 23190705 DOI: 10.1186/1471-2180-12-283]
42. Santacruz A, Marcos A, Wärnberg J, Martí A, Martin-Matillas M, Campoy C, Moreno LA, Veiga O, Redondo-Figuero C, Garagorri JM, Azcona C, Delgado M, García-Fuentes M, Collado MC, Sanz Y. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 2009; 17: 1906-1915 [PMID: 19390523 DOI: 10.1038/by.2009.112]
43. Abdallah Ismail N, Ragab SH, Abd Elbaky A, Shoeib AR, Alhosary Y, Fekry D. Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults. Arch Med Sci 2011; 7: 501-507 [PMID: 22295035 DOI: 10.5114/aoms.2011.23418]
44. Kalliomäki M, Collado MG, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008; 87: 534-538 [PMID: 18326589]
45. Karlsson CL, Onnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 2012; 20: 2257-2261 [PMID: 22546742 DOI: 10.1038/ oby.2012.110]
46. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MG, Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772 [PMID: 17456850]
47. Nadal I, Santacruz A, Marcos A, Warnberg J, Garagorri JM, Moreno LA, Martin-Matillas M, Campoy G, Marti A, Moleres A, Delgado M, Veiga OL, García-Fuentes M, Redondo CG, Sanz Y. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents, Int J Obes (Lond) 2009; 33: 758-767 [PMID: 19050675 DOI: 10.1038/ijo.2008.260]
48. Esteve E, Ricart W, Fernández-Real JM. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr Opin Clin Nutr Metab Care 2011; 14: 483-490 [PMID: 21681087 DOI: 10.1097/MCO.0b013e328348c06d]
49. Wostmann BS, Larkin C, Moriarty A, Bruckner-Kardoss E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab Anim Sci 1983; 33: 46-50 [PMID: 6834773]
50. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031 [PMID: 17183312 DOI: 10.1038/487047a]
51. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-484 [PMID: 19043404 DOI: 10.1038/nature07540]
52. Delzenne NM, Cani PD. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 2011; 31: 15-31 [PMID: 21568707 DOI: 10.1146/annurevnutr-072610-145146]
53. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 2010; 1801: 1175-1183 [PMID: 20691280 DOI: 10.1016/j.bbalip.2010.07.007]
54. Delzenne NM, Williams CM. Prebiotics and lipid metabolism. Curr Opin Lipidol 2002; 13: 61-67 [PMID: 11790964]
55. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003; 278: 25481-25489 [PMID: 12711604]
56. Stoddart LA, Smith NJ, Milligan G. International Union of Pharmacology. LXXI. Free fatty acid receptors FF A1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol Rev 2008; 60: 405-417 [PMID: 19047536 DOI: 10.1124/ pr.108.00802]
57. Bjursell M, Admyre T, Göransson M, Marley AE, Smith DM, Oscarsson J, Bohlooly-Y M. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab 2011; 300: E211-E220 [PMID: 20959533 DOI: 10.1152/ajpen-do.00229.2010]
58. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 2008; 149: 4519-4526 [PMID: 18499755 DOI: 10.1210/en.2008-0059]
59. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, Krakoff J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011; 94: 58-65 [PMID: 21543530 DOI: 10.3945/ajcn.110.010132]
60. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-15723 [PMID: 15505215]
61. Man dard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, Kleemann R, Bakker A, Veenman F, Wahli W, Müller M, Kersten S. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/ PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 2004; 279: 34411-34420 [PMID: 15190076]
62. Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012; 2012: 879151 [PMID: 22315672 DOI: 10.1155/2012/879151]
63. Arslan N, Tokgoz Y, Kume T, Bulbul M, Saym O, Harmanci D, Akdogan GG. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents. J Pediatr Endocrinol Metab 2013; 26: 1141-1147 [PMID: 23740679 DOI: 10.1515/jpem-2013-0029]
64. Wang XA, Zhang R, She ZG, Zhang XF, Jiang DS, Wang T, Gao L, Deng W, Zhang SM, Zhu LH, Guo S, Chen K, Zhang XD, Liu DP, Li H. Interferon regulatory factor 3 constrains IKK(3/NF-KB signaling to alleviate hepatic steatosis and insulin resistance. Hepatology 2014; 59: 870-885 [PMID: 24123166 DOI: 10.1002/hep.26751]
65. Leon-Cabrera S, Solís-Lozano L, Suárez-Alvarez K, González-Chávez A, Béjar YL, Robles-Díaz G, Escobedo G. Hyperleptinemia is associated with parameters of lowgrade systemic inflammation and metabolic dysfunction in obese human beings. Front Integr Neurosci 2013; 7: 62 [PMID: 23986664 DOI: 10.3389/fnint.2013.00062]
66. Machado MV, Cortez-Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol 2012; 11: 440-449 [PMID: 22700625]
67. Miele L, Marrone G, Lauritano G, Cefalo C, Gasbarrini A, Day G, Grieco A. Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Curr Pharm Des 2013; 19: 5314-5324 [PMID: 23432669]
68. IIan Y. Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18: 2609-2618 [PMID: 22690069 DOI: 10.3748/wjg.v18. i21.2609]
69. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 2010; 299: G440-G448 [PMID: 20508158 DOI: 10.1152/ajpgi.00098.2010]
70. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328: 228-231 [PMID: 20203013 DOI: 10.1126/science.1179721]
71. Lam YY, Ha CW, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J, Cook DI, Hunt NH, Caterson ID, Holmes AJ, Storlien LH. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 2012; 7: e34233 [PMID: 22457829 DOI: 10.1371/journal. pone.0034233]
72. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007; 86: 1286-1292 [PMID: 17991637]
73. Hawkesworth S, Moore SE, Fulford AJ, Barclay GR, Darboe A A, Mark H, Nyan OA, Prentice AM. Evidence for metabolic endotoxemia in obese and diabetic Gambian women. Nutr Diabetes 2013; 3: e83 [PMID: 23978817 DOI: 10.1038/ nutd.2013.24]
74. Harte AL, da Silva NF, Creely SJ, McGee KG, Billyard T, Youssef-Elabd EM, Tripathi G, Ashour E, Abdalla MS, Sharada HM, Amin AI, Burt AD, Kumar S, Day CP, McTernan PG. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond) 2010; 7: 15 [PMID: 20353583 DOI: 10.1186/1476-9255-7-15]
75. Verdam FJ, Rensen SS, Driessen A, Greve JW, Buurman WA. Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis. J Clin Gastroenterol 2011; 45: 149-152 [PMID: 20661154 DOI: 10.1097/ MCG.0b013e3181e12c24]
76. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC, Crowley J, Yanagisawa M, Gordon JI. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 2008; 105: 16767-16772 [PMID: 18931303 DOI: 10.1073/ pnas.0808567105]
77. Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 2005; 93 Suppl 1: S157-S161 [PMID: 15877889]
78. Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J Nutr 2000; 130: 1314-1319 [PMID: 10801936]
79. Hoefert B. Uber die bakterienbefunde im duodenalsaft von gesunden und kraken. Zschr Klin Med 1921; 92: 221-235
80. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000; 119: 1340-1347 [PMID: 11054393]
81. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of nonalcoholic steatohepatitis. J Hepatol 2007; 47: 571-579 [PMID: 17644211]
82. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 2011; 108 Suppl 1: 4523-4530 [PMID: 20837534 DOI: 10.1073/pnas.l006734107]
83. Sabaté JM, Jouet P, Harnois F, Mechler C, Msika S, Grossin M, Coffin B. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 2008; 18: 371-377 [PMID: 18286348 DOI: 10.1007/s11695-007-9398-2]
84. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009; 49: 1877-1887 [PMID: 19291785 DOI: 10.1002/hep.22848]
85. Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, McGilvray ID, Allard JP. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013; 58: 120-127 [PMID: 23401313 DOI: 10.1002/hep.26319]
86. Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect 2013; 19: 338-348 [PMID: 23452163 DOI: 10.1111/1469-0691.12140]
87. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411-420 [PMID: 18469830 DOI: 10.1038/ nri2316]
88. Lichtman SN, Keku J, Schwab JH, Sartor RB. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 1991; 100: 513-519 [PMID: 1985047]
89. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48: 206-211 [PMID: 11156641]
90. Shanab AA, Scully P, Crosbie O, Buckley M, O'Mahony L, Shanahan F, Gazareen S, Murphy E, Quigley EM. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci 2011; 56: 1524-1534 [PMID: 21046243 DOI: 10.1007/s10620-010-1447-3]
91. Cäbele E, Dostert K, Hofmann C, Wiest R, Schölmerich J, Hellerbrand C, Obermeier F. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol 2011; 55: 1391-1399 [PMID: 21703208 DOI: 10.1016/j.jhep.2011.02.035]
92. Alisi A, Ceccarelli S, Panera N, Nobili V. Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Front Cell Infect Microbiol 2012; 2: 132 [PMID: 23112961 DOI: 10.3389/fcimb.2012.00132.]
93. De Gottardi A, McCoy KD. Evaluation of the gut barrier to intestinal bacteria in non-alcoholic fatty liver disease. J Hepatol 2011; 55: 1181-1183 [PMID: 21703167 DOI: 10.1016/ j.jhep.2011.05.003]
94. Ye D, Li FY, Lam KS, Li H, Jia W, Wang Y, Man K, Lo CM, Li X, Xu A. Toll-like receptor-4 mediates obesity-induced nonalcoholic steatohepatitis through activation of X-box binding protein-1 in mice. Gut 2012; 61: 1058-1067 [PMID: 22253482 DOI: 10.1136/gutjnl-2011-300269]
95. Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, Knauf C, Peiretti F, Verdier M, Juhan-Vague I, Tanti JF, Burcelin R, Alessi MC. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007; 50: 1267-1276 [PMID: 17426960]
96. Saberi M, Woods NB, de Luca C, Schenk S, Lu JC, Bandyopadhyay G, Verma IM, Olefsky JM. Hematopoietic cellspecific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 2009; 10: 419-429 [PMID: 19883619 DOI: 10.1016/ j.cmet.2009.09.006]
97. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 2009; 51: 212-223 [PMID: 19447517 DOI: 10.1016/j.jhep.2009.03.008]
98. Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH, Remick DG, Wang SC. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology 2000; 31: 932-936 [PMID: 10733550]
99. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997; 94: 2557-2562 [PMID: 9122234]
100. Rabelo F, Oliveira CP, Faintuch J, Mazo DF, Lima VM, Stefano JT, Barbeiro HV, Soriano FG, Alves VA, Carrilho FJ. Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis. Obes Surg 2010; 20: 906-912 [PMID: 20454933 DOI: 10.1007/s11695-010-0181-4]
101. Aoyama T, Paik YH, Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract 2010; 2010: [PMID: 20706677 DOI: 10.1155/2010/192543]
102. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003; 37: 1043-1055 [PMID: 12717385]
103. Guo J, Friedman SL. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair 2010; 3: 21 [PMID: 20964825 DOI: 10.1186/1755-1536-3-21]
104. Sanyal AJ, Campbell-Sargent G, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-1192 [PMID: 11266382]
105. Franchi L, Muñoz-Planillo R, Núñez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012; 13: 325-332 [PMID: 22430785 DOI: 10.1038/ni.2231]
106. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27: 229-265 [PMID: 19302040 DOI: 10.1146/annurev.immunol.021908.132715]
107. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-225 [PMID: 21124315 DOI: 10.1038/nature09663]
108. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-185 [PMID: 22297845 DOI: 10.1038/naturel0809]
109. Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake, J Nutr 2008; 138: 1452-1455 [PMID: 18641190]
110. Alisi A, Manco M, Devito R, Piemonte F, Nobili V. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children, J Pediatr Gastroenterol Nutr 2010; 50: 645-649 [PMID: 20400911 DOI: 10.1097/MPG.0b013e3181c7bdfl]
111. Ruiz AG, Casafont F, Crespo J, Gayón A, Mayorga M, Estebanez A, Fernadez-Escalante JC, Pons-Romero F. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 2007; 17:1374-1380 [PMID: 18000721]
112. Vance DE. Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr Opin Lipidol 2008; 19: 229-234 [PMID: 18460912 DOI: 10.1097/ MOL.0b013e3282fee935]
113. Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Curr Opin Microbiol 2013; 16: 246-254 [PMID: 23880135 DOI: 10.1016/j.mib.2013.07.002]
114. Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J, Ament ME. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 1995; 22: 1399-1403 [PMID: 7590654]
115. Zeisel SH, Wishnok JS, Blusztajn JK. Formation of methylamines from ingested choline and lecithin, J Pharmacol Exp Ther 1983; 225: 320-324 [PMID: 6842395]
116. Wang Z, Klipfell E, Bennett BJ, Koeth R, Le vison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63 [PMID: 21475195 DOI: 10.1038/nature09922]
117. Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011; 140: 976-986 [PMID: 21129376 DOI: 10.1053/j.gastro.2010.11.049]
118. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC, Mitchell SC, Holmes E, McCarthy MI, Scott J, Gauguier D, Nicholson JK. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006; 103: 12511-12516 [PMID: 16895997]
119. Fuchs M. Non-alcoholic Fatty liver disease: the bile Acidactivated farnesoid x receptor as an emerging treatment target, J Lipids 2012; 2012: 934396 [PMID: 22187656 DOI: 10.1155/2012/934396]
120. Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M. Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 2010; 28: 220-224 [PMID: 20460915 DOI: 10.1159/000282091]
121. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, Pellicciari R, Auwerx J, Schoonjans K. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10: 167-177 [PMID: 19723493 DOI: 10.1016/j.cmet.2009.08.001]
122. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in 1110-/- mice. Nature 2012; 487: 104-108 [PMID: 22722865 DOI: 10.1038/naturell225]
123. Turnbaugh PJ. Microbiology: fat, bile and gut microbes. Nature 2012; 487: 47-48 [PMID: 22763552]
124. Gustot T, Lemmers A, Moreno C, Nagy N, Quertinmont E, Nicaise C, Franchimont D, Louis H, Devière J, Le Moine O. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 2006; 43: 989-1000 [PMID: 16628628]
125. Volynets V, Küper MA, Strahl S, Maier IB, Spruss A, Wagnerberger S, Königsrainer A, Bischoff SC, Bergheim I. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 2012; 57: 1932-1941 [PMID: 22427130 DOI: 10.1007/S10620-012-2112-9]
126. Nair S, Cope K, Risby TH, Diehl AM. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 2001; 96: 1200-1204 [PMID: 11316170]
127. Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013; 57: 601-609 [PMID: 23055155 DOI: 10.1002/hep.26093]
128. Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A. Role of snail activation in alcohol-induced iNOS-mediated disruption of intestinal epithelial cell permeability. Alcohol Clin Exp Res 2011; 35: 1635-1643 [PMID: 21535025 DOI: 10.1111/j.l530-0277.2011.01510.x]